Befiradol-Impurities | Pharmaffiliates

befiradol

Befiradol was discovered and developed by Pierre Fabre Médicament, a French pharmaceuticals company.It is an experimental drug being studied for the treatment of levodopa-induced dyskinesia. Reference standards of Befiradol API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Befiradol - API Standards 
    [catalogue_number] => PA 02 98000
    [category_ids] => ,79,80,89,
    [chemical_name] => 
    [weight] => 393.86
    [form] => C20H22ClF2N3O
    [cas] => 208110-64-9
    [pslug] => 208110-64-9-befiradol-api-pa0298000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 98000

Befiradol - API Standards


  • Catalogue No.:PA 02 98000

  • CAS :

    208110-64-9

  • Molecular Formula : C20H22ClF2N3O

  • Molecular Weight : 393.86